Boston Bioprocess Inc.

Boston Bioprocess is a biotechnology company that provides a dual-offering of contract development and manufacturing organization (CDMO) services alongside a proprietary software platform. Its CDMO services leverage benchtop and pilot-scale fermentation assets, ranging from 1.5L to 1,500L, to support fermentation development, downstream processing, and analytical testing for clients in sectors such as biopharma, food and beverage, and specialty chemicals. Complementing these wet lab capabilities, the company has developed an AI-driven platform that functions as a manufacturing execution system (MES), data manager, and process optimizer. This software allows operators to design processes, manage inventory and assets, track batch records, and utilize AI models to improve titer, yield, and overall productivity.

These integrated solutions are designed to help growth-stage and commercial biotech leaders accelerate development cycles, optimize production performance, and reduce manufacturing costs. By providing both the physical infrastructure for scale-up and the digital tools for process intelligence, Boston Bioprocess addresses common challenges in biomanufacturing such as process yield optimization and tech transfer. The company's multidisciplinary approach combines scientific expertise with automated execution and data analysis, enabling partners to iterate quickly and transition smoothly from development to commercial manufacturing. Headquartered in Champaign, Illinois, the firm has supported various clients through significant development milestones and scale-up projects.